4-vinyl-1-cyclohexene dioxide has been researched along with Cardiovascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Heo, JD; Joo, BS; Joo, JK; Lee, HJ; Park, MJ | 1 |
| Brooks, HL; Cannon, DK; Chen, H; Constantopoulos, E; Konhilas, JP; Lipovka, Y; Lopez-Pier, M; McKee, LA; Pollow, D; Regan, JA; Sanchez, JN; Skaria, R | 1 |
| Brooks, HL; Hoyer, PB; Pollow, DP | 1 |
1 review(s) available for 4-vinyl-1-cyclohexene dioxide and Cardiovascular Diseases
| Article | Year |
|---|---|
The VCD Mouse Model of Menopause and Perimenopause for the Study of Sex Differences in Cardiovascular Disease and the Metabolic Syndrome.
Topics: Animals; Cardiovascular Diseases; Cyclohexenes; Diabetic Nephropathies; Disease Models, Animal; Female; Humans; Male; Menopause; Metabolic Syndrome; Mice; Ovary; Perimenopause; Sex Characteristics; Vinyl Compounds | 2016 |
2 other study(ies) available for 4-vinyl-1-cyclohexene dioxide and Cardiovascular Diseases
| Article | Year |
|---|---|
Timing of hormone therapy and its association with cardiovascular risk and metabolic parameters in 4-vinylcyclohexene diepoxide-induced primary ovarian insufficiency mouse model.
Topics: Animals; Cardiovascular Diseases; Cholesterol; Cytokines; Disease Models, Animal; Estradiol; Female; Heart Disease Risk Factors; Humans; Mice; Primary Ovarian Insufficiency; Risk Factors | 2023 |
Using 4-vinylcyclohexene diepoxide as a model of menopause for cardiovascular disease.
Topics: Angiotensin II; Animals; Atrial Remodeling; Blood Pressure; Cardiovascular Diseases; Cyclohexenes; Female; Menopause; Mice; Models, Animal; Vinyl Compounds | 2020 |